Abbott Laboratories (ABT) vs Medtronic (MDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Medtronic (MDT) has outperformed Abbott Laboratories (ABT) over the past year, losing 13.0% versus a loss of 25.8%. Over five years, ABT leads with a -16.0% price change compared with -33.1% for MDT. Abbott Laboratories is the larger company by market cap ($170.84 billion vs $109.38 billion), about 1.6 times the size, while Medtronic is growing revenue faster (+8.4% vs +5.7%).
On valuation, Medtronic trades at a lower forward P/E (13.3x vs 16.3x for Abbott Laboratories). Medtronic offers the higher dividend yield (3.33% vs 2.51%). Abbott Laboratories converts more of its revenue into profit, with a net margin of 14.7% versus 13.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABT | MDT |
|---|---|---|
| Share price | $98.73 | $85.51 |
| Market cap | $170.84B | $109.38B |
| 1-day change | +0.58% | -1.81% |
| YTD return | -21.20% | -10.98% |
| 1-year return | -25.78% | -13.04% |
| 5-year return | -15.97% | -33.06% |
| P/E ratio (TTM) | 31.64 | 21.38 |
| Forward P/E | 16.28 | 13.33 |
| EPS (TTM) | $3.12 | $4.00 |
| Dividend yield | 2.51% | 3.33% |
| Annual dividend | $2.48 | $2.85 |
| Revenue (latest FY) | $44.33B | $36.36B |
| Revenue growth (YoY) | +5.67% | +8.43% |
| Net income (latest FY) | $6.52B | $4.80B |
| Gross margin | 56.42% | 65.02% |
| Operating margin | 18.17% | 17.78% |
| Net margin | 14.72% | 13.20% |
| 52-week high | $135.13 | $106.33 |
| 52-week low | $81.97 | $73.31 |
| Distance from 52-week high | -26.94% | -19.58% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +22.27% | +22.14% |
| Average volume | 9.56M | 10.71M |
| Shares outstanding | 1.73B | 1.28B |
| Employees | 122,000 | 95,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MDT has outperformed ABT by 12.7 percentage points over the past year.
- Abbott Laboratories trades at a higher earnings multiple (31.6x vs 21.4x trailing P/E).
About Abbott Laboratories
ABT stock →Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Health Care · Biotechnology: Pharmaceutical Preparations · 122,000 employees
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 95,000 employees
ABT vs MDT FAQ
Which is bigger, Abbott Laboratories or Medtronic?
Abbott Laboratories (ABT) is larger, with a market capitalization of $170.84B compared with $109.38B for Medtronic (MDT).
Which stock has performed better over the past year, ABT or MDT?
MDT returned -13.04% over the past 12 months, compared with -25.78% for ABT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ABT or MDT?
MDT has the lower trailing P/E at 21.4, versus 31.6 for ABT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Abbott Laboratories or Medtronic?
Medtronic has the higher yield at 3.33%, compared with 2.51% for Abbott Laboratories.
Are Abbott Laboratories and Medtronic in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Abbott Laboratories and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Medtronic.